(Q24612292)

English

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia (English)

0 references

1 reference

based on heuristic

inferred from title

John Fitzgerald

object named as

John D Fitzgerald

2

0 references

object named as

Tuhina Neogi

6

0 references

Michael Pillinger

object named as

Michael H Pillinger

7

0 references

Fernando Perez-Ruiz

object named as

Fernando Perez-Ruiz

13

0 references

William J Taylor

14

object named as

Will Taylor

0 references

Frédéric Lioté

object named as

Frédéric Lioté

15

0 references

Jasvinder Singh

object named as

Jasvinder A Singh

17

0 references

18

object named as

Nicola Dalbeth

0 references

3

object named as

Puja P Khanna

0 references

24

object named as

Gail Kerr

0 references

1

object named as

Dinesh Khanna

0 references

4

object named as

Sangmee Bae

0 references

8

object named as

Joan Merill

0 references

Shraddha Prakash

10

object named as

Shraddha Prakash

0 references

11

object named as

Marian Kaldas

0 references

12

object named as

Maneesh Gogia

0 references

16

object named as

Hyon Choi

0 references

19

object named as

Sanford Kaplan

0 references

Steven A Yarows

22

object named as

Steven A Yarows

0 references

23

object named as

Blake Roessler

0 references

R. Lawrence Edwards

28

object named as

N Lawrence Edwards

0 references

32

object named as

Neil Wenger

0 references

Robert Terkeltaub

33

object named as

Robert Terkeltaub

0 references

author name string

Manjit K Singh

5

0 references

Susan Lee

9

0 references

Vandana Niyyar

20

0 references

Danielle Jones

21

0 references

Charles King

25

0 references

Gerald Levy

26

0 references

Daniel E Furst

27

0 references

Brian Mandell

29

0 references

H Ralph Schumacher

30

0 references

Mark Robbins

31

0 references

language of work or name

0 references

publication date

October 2012

0 references

Arthritis Care and Research

0 references

64

0 references

10

0 references

1431-46

0 references

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

7 April 2017

EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

7 April 2017

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

7 April 2017

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

7 April 2017

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

7 April 2017

Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

7 April 2017

Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

7 April 2017

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

7 April 2017

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

7 April 2017

Gout and the risk of acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

7 April 2017

2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Allopurinol pharmacogenetics: assessment of potential clinical usefulness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Clinical utility of dual-energy CT for evaluation of tophaceous gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Clinical practice. Gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Risk factors for gout and prevention: a systematic review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Chronic gout: epidemiology, disease progression, treatment and disease burden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Gout and its comorbidities.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Update on gout: new therapeutic strategies and options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

A prescription for lifestyle change in patients with hyperuricemia and gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Adherence with urate-lowering therapies for the treatment of gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Long-term cardiovascular mortality among middle-aged men with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Quality of care for gout in the US needs improvement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Clinical guidelines: developing guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Allopurinol hypersensitivity syndrome: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

27 September 2017

Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

30 May 2018

Assessment of tophus size: a comparison between physical measurement methods and dual-energy computed tomography scanning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Quality of life and disability in patients with treatment-failure gout.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Dual energy computed tomography in tophaceous gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Alcohol consumption as a trigger of recurrent gout attacks.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol-related toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Summary of the Dutch College of General Practitioners' "Gout" Standard

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683400

28 November 2018

Epidemiology of gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/23024028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008

1 reference

https://pubmed.ncbi.nlm.nih.gov/23024028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An exploratory ultrasound study of early gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/23024028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23024028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol

1 reference

https://pubmed.ncbi.nlm.nih.gov/23024028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a thiazide-allopurinol drug interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/23024028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term uricosuric therapy in gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/23024028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/23024028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Revised version of Guideline for the Management of Hyperuricemia and Gout]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23024028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fructose-rich beverages and risk of gout in women

1 reference

https://api.crossref.org/works/10.1002%2FACR.21772

7 January 2021

based on heuristic

inferred from DOI database lookup

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.21772

7 January 2021

based on heuristic

inferred from DOI database lookup

Alcohol intake and risk of incident gout in men: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FACR.21772

7 January 2021

based on heuristic

inferred from DOI database lookup

Purine-rich foods, dairy and protein intake, and the risk of gout in men.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21772

7 January 2021

based on heuristic

inferred from DOI database lookup

Purine-rich foods intake and recurrent gout attacks

1 reference

https://api.crossref.org/works/10.1002%2FACR.21772

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21772

7 January 2021

based on heuristic

inferred from DOI database lookup

Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2FACR.21772

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/ACR.21772

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24612292&oldid=1951408415"